*ST Suwu: Datou medical claims 1.6 billion yuan*

date
11/08/2025
*ST Suwu announced that its controlling subsidiary, Datou Medical, has filed for arbitration with the Shenzhen International Arbitration Court regarding the breach of contract case involving Regen Biotech, Inc., and the case was officially accepted on August 7, 2025. Datou Medical's arbitration request is to confirm the validity of the "Exclusive Agency Agreement" and continue to perform it. If not supported, an initial claim of losses totaling 1.6 billion RMB, including market development costs, breach of contract losses, and loss of potential profits, will be made, with the right to adjust the claim amount reserved. There is uncertainty in the arbitration result, and the company's stock may face delisting due to significant illegal actions. Investors are advised to be aware of the risks.